Access and use of oxytocin for postpartum haemorrhage prevention: a pre-post study targeting the poorest in six Mesoamerican countries
Authors:
Open Access
Abstract
Objectives Haemorrhage remains the leading cause of maternal mortality in Central America. The Salud Mesoamérica Initiative aims to reduce such mortality via performance indicators. Our objective was to assess the availability and administration of oxytocin, before and after applying Salud Mesoamérica Initiative interventions in the poorest health facilities across Central America. Design Pre-post study. Setting 166 basic-level and comprehensive-level health facilities in Belize, Guatemala, Honduras, Mexico, Nicaragua and Panama. Participants A random sample of medical records for uncomplicated full-term deliveries (n=2470) per International Classification of Diseases coding at baseline (July 2011 to August 2013) and at first-phase follow-up (January 2014 to October 2014). Interventions A year of intervention implementation prior to first-phase follow-up data collection focused on improving access to oxytocin by strengthening supply chains, procurement, storage practices and pharmacy inventory monitoring, using a results-based financing model. Primary and secondary outcome measures Oxytocin availability (primary outcome) and administration (secondary outcome) for postpartum haemorrhage prevention. Results Availability of oxytocin increased from 82.9% to 97.6%. Oxytocin administration increased from 83.6% to 88.4%. Significant improvements were seen for availability of oxytocin (adjusted OR (aOR)=8.41, 95% CI 1.50 to 47.30). Administration of oxytocin was found to be significantly higher in Honduras (aOR=2.96; 95% CI 1.00 to 8.76) in reference to Guatemala at follow-up. Conclusion After interventions to increase health facility supplies, the study showed a significant improvement in availability but not administration of oxytocin in poor communities within Mesoamerica. Efforts are needed to improve the use of oxytocin.Keywords
Funding Information
- Bill and Melinda Gates Foundation (OPPGH5328)
- Carlos Slim Foundation (10.13039/100004429)
- National Institute for Health Research (T32GM086270)
- Agencia Española de Cooperación Internacional para el Desarrollo (10.13039/501100004892)
This publication has 24 references indexed in Scilit:
- Postpartum haemorrhage management, risks, and maternal outcomes: findings from the World Health Organization Multicountry Survey on Maternal and Newborn HealthBJOG: An International Journal of Obstetrics & Gynaecology, 2014
- Improving maternal health and safety through adherence to postpartum hemorrhage protocol in Latin AmericaInternational Journal of Gynecology & Obstetrics, 2014
- Helping mothers survive bleeding after birth: an evaluation of simulation‐based training in a low‐resource settingActa Obstetricia et Gynecologica Scandinavica, 2014
- Reduced postpartum hemorrhage after implementation of active management of the third stage of labor in rural HondurasInternational Journal of Gynecology & Obstetrics, 2012
- Prevention and treatment of postpartum hemorrhage in low-resource settingsInternational Journal of Gynecology & Obstetrics, 2012
- Progress towards Millennium Development Goals 4 and 5 on maternal and child mortality: an updated systematic analysisThe Lancet, 2011
- Using Uniject to increase the use of prophylactic oxytocin for management of the third stage of labor in Latin AmericaInternational Journal of Gynecology & Obstetrics, 2011
- An Education and Motivation Intervention to Change Clinical Management of the Third Stage of Labor—The GIRMMAHP InitiativeBirth, 2008
- Prophylactic oxytocin for the third stage of labour2001
- The Bristol third stage trial: active versus physiological management of third stage of labour.BMJ, 1988